GLOBAL CANCER IMMUNOTHERAPY SUMMIT

    In this summit, the most successful and promising new cancer treatment strategies will be explored. This summit is one of the most important opportunities, where you will explore the best practices in cancer immunotherapy. It is particularly important for the fields key opinion leaders, most exciting newcomers and others to come together to discuss and learn about the up-to-the-minute trends.
    The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities. This premier B2B summit is one of the few opportunities, where you will meet face to face with leading industry professionals and decision makers and discuss your business potential and opportunities. It will also enable the participants to learn about the most advanced techniques and tools through which they can assess their portfolios and development potential.

    KEY TOPICS

    EU and US Regulatory aspects

    Management of side effects

    What’s new in specific cancer types – News in specific cancer types

    The true potential of the next generation immune checkpoint pathways

    Resistance to therapy

    Patient selection and predictive biomarkers

    Advancements in T-cell engineering

    Commercialization of Viable T-cell therapies

    Revolutionary cancer treatment with personalised cancer vaccines

    Combining immune checkpoint inhibitors with chemotherapy or radiotherapy and beyond

    Technological developments

    Preclinical and clinical progress in Cancer Immunotherapy

    Advanced methods, technological developments and strategies in Cancer Immunotherapy

    Imaging and nuclear medicine and design of immuno-oncology trials

    Progressive genetic engineering techniques

    WHY YOU SHOULD BE HERE ?

    Network with business development and licensing professionals as well as professionals in your sector

    Implement the latest innovations

    Learn about the latest technologies and most pressing topics specific to your business

    Get an overview on innovative emerging technologies and promote business partnerships within the sector

    Interact and connect with leading professionals

    Discuss about new opportunities for your products and services with key decision makers

    FEATURED SPEAKERS

    Close

    Schedule

    DAY 1
    9:10
    INNOVATIONS IN CANCER IMMUNOTHERAPY: Case Study
    Current trends in cell and gene therapies
    Stefanos Theoharis
    INNOVATIONS IN CANCER IMMUNOTHERAPY: Case Study
    11:00
    Case Study
    Oncolytic viruses as novel cancer immunotherapeutic
    Dr. rer. nat. Jennifer Altomonte
    12:20
    Case Study
    Advancements in T-cell engineering (and its
    commercialization)
    14:00
    ADVANCED METHODS, TECHNOLOGICAL DEVELOPMENTS AND STRATEGIES: Case Study
    Intra-tumoural delivery of panErbB-targeted T4
    CAR-T Immunotherapyto treat locally advanced
    or recurrent head and neck cancer
    Dr. John Maher
    14:40
    Case Study
    Checkpoint inhibitor molecules Yervoy, Opdivo
    and Keytruda
    Louis Boon
    15:40
    Case Study
    Cancer treatment with personalized vaccines
    Prof. Bernard A. M. Van der Zeijst, PhD
    16:20
    Panel Discussion
    T-cell engineering and its commercialization
    With Speakers of the day Moderated by the Chairperson
    DAY 2
    9:40
    FUTURE TRENDS/APPROACHES: Case Study
    PI3K/mTOR signalling in immunooncology
    Larissa S. Carnevalli, PhD
    FUTURE TRENDS/APPROACHES: Case Study
    10:20
    Case Study
    The emerging role of immunotherapy in
    breast cancer
    Ivan Diaz-Padilla, MD, PhD
    11:30
    Case Study
    Are highly mutated tumors more “attractive” for
    the immune system?
    Dr. Marek Štastný, PhD
    12:10
    Case Study
    Use of bacteria for immunotherapy
    13:50
    Case Study
    The Evolution of Imaging Endpoints
    Madalin Sevestrian
    14:30
    Case Study
    Regulatory aspects in EU and US
    Ronald Kurt Kuoch
    15:30
    Panel Discussion
    The future of Cancer Immunotherapy
    With Speakers of the day Moderated by the Chairperson

    FEATURED COMPANIES

    MEDIA PARTNERS

    REQUEST FORM








    GREAT OFFERS, RIGHT IN YOUR INBOX!

    Subscribe to our newsletter and get up-to-date information regarding the ``Global Cancer Immunotherapy Summit``

    Copyright 2017 © Sharonat Group s.r.o. All rights reserved.

    Send